Advertisement

Ads Placeholder
Loading...

NeuroSense Therapeutics Ltd.

NRSNW•NASDAQ
Healthcare
Biotechnology
$0.22
$0.02(9.85%)
U.S. Market opens in 43h 48m

NeuroSense Therapeutics Ltd. (NRSNW) Stock Overview

Explore NeuroSense Therapeutics Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.4M
P/E Ratio-3.24
EPS (TTM)$-0.94
ROE-12.64%
Fundamental Analysis

AI Price Forecasts

1 Month$0.28
3 Months$0.59
1 Year Target$0.52

NRSNW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroSense Therapeutics Ltd. (NRSNW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.24 and a market capitalization of 5.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
9.85%
5-Day Change
9.85%
1-Month Change
5.63%
3-Month Change
-27.03%
6-Month Change
-42.18%
Year-to-Date (YTD) Change
-27.03%
1-Year Change
7.75%
3-Year Change
-35.54%
5-Year Change
-78.25%
All-Time (Max) Change
-78.25%

Contact Information

https://www.neurosense-tx.com
972 9 953 1142
Medinat ha-Yehudim Street 85, Herzliya, NaN, 4676670

Company Facts

170 Employees
CountryIL
Actively Trading

Frequently Asked Questions